Gemcitabine, sold under the brand name Gemzar, among others, is a chemotherapy medication used to treat cancers. It is used to treat testicular cancer, breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer. It is administered by intravenous infusion. It acts against neoplastic growth, and it inhibits the replication of Orthohepevirus A, the causative agent of Hepatitis E, through upregulation of interferon signaling.
It is used as a second-line treatment in combination with paclitaxel for breast cancer that is metastatic or cannot be surgically removed.
It is used as a second-line treatment in combination with carboplatin for ovarian cancer.
It is used as a first-line treatment alone for pancreatic cancer.
It is used in combination with cisplatin for advanced or metastatic bladder cancer.
It is used in combination with cisplatin for advanced or metastatic non-small cell lung cancer.
Open Part | Close Part | IP | BP | USP | EP |
---|---|---|---|---|---|
Available | Available |